Hints and tips:
...Lack of scale is not necessarily a disadvantage, Medacta’s 32 per cent operating margins are in line with large peers such as Zimmer Biomet and DePuy Synthes....
...For Medtronic, it would mean diversification away from its traditional focus (spine)....
...Another US rival Zimmer, the maker of joint replacement technology, acquired Biomet in a blockbuster deal worth $13.4bn....
...After the Biomet acquisition was announced, Mr Bohuon said he felt Smith & Nephew could benefit from consolidation among its rivals....
...These makers of hip and knee joint replacements and spine implants are benefiting, like the drugs industry, from the ageing population....
...Toward the end of 2003 I found it in the handful of companies that dominate the market for hip and knee joint replacements and spine implants....
International Edition